{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:23:03Z","timestamp":1761844983736,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10157-018-1675-y","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:04:50Z","timestamp":1542845090000},"page":"544-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interleukin-33\/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli"],"prefix":"10.1007","volume":"23","author":[{"given":"Shimpei","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1077-7772","authenticated-orcid":false,"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mondo","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotoshi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"1675_CR1","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","volume":"25","author":"C Zoja","year":"2010","unstructured":"Zoja C, Buelli S, Morigi M. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol. 2010;25:2231\u201340.","journal-title":"Pediatr Nephrol"},{"key":"1675_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"J Scheiring","year":"2008","unstructured":"Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol. 2008;23:1749\u201360.","journal-title":"Pediatr Nephrol"},{"key":"1675_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/088307388900400206","volume":"4","author":"JS Hahn","year":"1989","unstructured":"Hahn JS, Havens PL, Higgins JJ, O\u2019Rourke PP, Estroff JA, Strand R. Neurological complications of hemolytic-uremic syndrome. J Child Neurol. 1989;4:108\u201313.","journal-title":"J Child Neurol"},{"key":"1675_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0022-3476(94)70001-X","volume":"125","author":"RL Siegler","year":"1994","unstructured":"Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr. 1994;125:511\u20138.","journal-title":"J Pediatr"},{"key":"1675_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jneuroim.2008.02.012","volume":"196","author":"M Shiraishi","year":"2008","unstructured":"Shiraishi M, Ichiyama T, Matsushige T, Iwaki T, Iyoda K, Fukuda K, et al. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy. J Neuroimmunol. 2008;196:147\u201352.","journal-title":"J Neuroimmunol"},{"key":"1675_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.cyto.2012.07.038","volume":"60","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Kuroda M, Sakashita N, Konishi M, Kaneda H, Igarashi N, et al. Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. Cytokine. 2012;60:694\u2013700.","journal-title":"Cytokine"},{"key":"1675_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2013.12.005","volume":"66","author":"M Shimizu","year":"2014","unstructured":"Shimizu M, Kuroda M, Inoue N, Konishi M, Igarashi N, Taneichi H, et al. Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. Cytokine. 2014;66:1\u20136.","journal-title":"Cytokine"},{"key":"1675_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10157-016-1254-z","volume":"21","author":"M Shimizu","year":"2017","unstructured":"Shimizu M, Inoue N, Kuroda M, Mizuta M, Sugimoto N, Kaneda H, et al. Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli. Clin Exp Nephrol. 2017;21:76\u201382.","journal-title":"Clin Exp Nephrol"},{"key":"1675_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39:1003\u201318.","journal-title":"Immunity"},{"key":"1675_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","volume":"31","author":"C Cayrol","year":"2014","unstructured":"Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31\u20137.","journal-title":"Curr Opin Immunol"},{"key":"1675_CR11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/j.1460-2075.1994.tb06367.x","volume":"13","author":"G Bergers","year":"1994","unstructured":"Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 1994;13:1176\u201388.","journal-title":"EMBO J"},{"key":"1675_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1432-1327.1999.00615.x","volume":"264","author":"H Iwahana","year":"1999","unstructured":"Iwahana H, Yanagisawa K, Ito-Kosaka A, Kuroiwa K, Tago K, Komatsu N, et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem. 1999;264:397\u2013406.","journal-title":"Eur J Biochem"},{"key":"1675_CR13","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","volume":"183","author":"D Pr\u00e9fontaine","year":"2009","unstructured":"Pr\u00e9fontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol. 2009;183:5094\u2013103.","journal-title":"J Immunol"},{"key":"1675_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3899\/jrheum.090492","volume":"37","author":"Y Matsuyama","year":"2010","unstructured":"Matsuyama Y, Okazaki H, Tamemoto H, Kimura H, Kamata Y, Nagatani K, et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol. 2010;37:18\u201325.","journal-title":"J Rheumatol"},{"key":"1675_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00467-014-2950-0","volume":"30","author":"K Buder","year":"2015","unstructured":"Buder K, Latal B, Nef S, Neuhaus TJ, Laube GF, Spart\u00e0 G. Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome. Pediatr Nephrol. 2015;30:503\u201313.","journal-title":"Pediatr Nephrol"},{"key":"1675_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000180229","volume":"11","author":"CA Gianantonio","year":"1973","unstructured":"Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET. The hemolytic uremic syndrome. Nephron. 1973;11:174\u201392.","journal-title":"Nephron"},{"key":"1675_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2011.02.045","volume":"1385","author":"S Yasuoka","year":"2011","unstructured":"Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M, et al. Production and functions of IL-33 in the central nervous system. Brain Res. 2011;1385:8\u201317.","journal-title":"Brain Res"},{"key":"1675_CR18","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1089\/neu.2016.4900","volume":"34","author":"G Wicher","year":"2017","unstructured":"Wicher G, Wallenquist U, Lei Y, Enoksson M, Li X, Fuchs B, et al. Interleukin-33 promotes recruitment of microglia\/macrophages in response to traumatic brain injury. J Neurotrauma. 2017;34:3173\u201382.","journal-title":"J Neurotrauma"},{"key":"1675_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-018-1169-6","volume":"15","author":"K Cao","year":"2018","unstructured":"Cao K, Liao X, Lu J, Yao S, Wu F, Zhu X, et al. IL-33\/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation. J Neuroinflammation. 2018;15:136.","journal-title":"J Neuroinflammation"},{"key":"1675_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2015.01.013","volume":"85","author":"SP Gadani","year":"2015","unstructured":"Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron. 2015;85:703\u20139.","journal-title":"Neuron"},{"key":"1675_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.164.2.2008120","volume":"164","author":"K Oshikawa","year":"2001","unstructured":"Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa KEN, Ohno S, et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med. 2001;164:277\u201381.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1675-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1675-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1675-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:25:43Z","timestamp":1574364343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1675-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1675-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}